Neoplasia/BPH

	Predictive molecular alterations of prostate cancer brain metastases based on a companion diagnostic assay. Discov Oncol Rodríguez-Calero A, Benjak A, Maletti S, Sanoyan DA, Zoche M, Nowak M, Moch H, Rubin MA. PMID: 41307785 [PubMed - as supplied by publisher]
	Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II study. Eur J Nucl Med Mol Imaging Marini I, Giunta EF, Nicolini S, Grassi I, Foca F, Sarnelli A, Di Iorio V, Vizza L, Giani E, Celli M, Monti M, Severi S, De Giorgi U, Borgia F, Paganelli G, Matteucci F, Sansovini M. PMID: 41307700 [PubMed - as supplied by publisher]
	Reply to Parth Aphale, Shashank Dokania, Himanshu Shekhar's Letter to the Editor re: Bahl A, Chilelli A, Faria R, et al. Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study. World J Urol 43:465. https://doi.org/10.1007/s00345-025-05841-9. World J Urol Bahl A, Chilelli A, Faria R, Rozario N, Snijder R, Stark S, Merseburger AS. PMID: 41307573 [PubMed - in process]
	Economic and disease burden of prostate cancer in expanded BRICS nations: systematic analysis of global burden of disease study 1990 - 2021. Expert Rev Anticancer Ther Satapathy P, Gaidhane AM, Puri D, Lakhanpal S, Mishra R, Kumar S, Arcot R, Satapathy P. PMID: 41307503 [PubMed - as supplied by publisher]
	Mitogen-activated protein kinase pathway and four genes involved in the development of benign prostatic hyperplasia: in vivo and vitro validation. Front Immunol Gu JM, Guo XP, Wu L, Li LY, Zhu C, Deng T, Wang SY, Fang C, Zeng XT. PMID: 41306978 [PubMed - indexed for MEDLINE]
	Identification of biomarkers of Shenhailong formula in benign prostatic hyperplasia treatment: An observation study using network pharmacology and Mendelian randomization analysis. Medicine (Baltimore) Pan J, Yu M, Zhang L, Yin J, Liu J, Zhang S, Zhang P, Fan Q, Liu J, Li X. PMID: 41305716 [PubMed - indexed for MEDLINE]
	Causal insights into immune cell profiles, plasma metabolites, and bladder cancer: A Mendelian randomization approach. Medicine (Baltimore) Yang J, Xu Z, Tao B, Zhao Y, Ma Y, Niu Y, He Y, Wu J, Wang L, Zhong Z. PMID: 41305704 [PubMed - indexed for MEDLINE]
	Enhanced Deep Neural Network for Prostate Segmentation in Micro-Ultrasound Images. Sensors (Basel) Al-Qurri A, Thaher A, Almekkawy MK. PMID: 41305024 [PubMed - indexed for MEDLINE]
	Recent Advances in Androgen Receptor Pathway Inhibitors for Castration-Sensitive Prostate Cancer. Pharmaceuticals (Basel) Lancia A, Oderda M, Camilli F, Festa E, Bottero M, Alì E, La Mattina S, Bonzano E, Saddi J, Detti B, Santos Hernandez DA, Ingrosso G. PMID: 41304942 [PubMed]
	Histopathological Scoring of Renal Injury in an Experimental Model of Acute Pancreatitis Caused by Karwinskia humboldtiana Fruit: Exploring Its Potential Utility in the Treatment of Pancreatic Cancer. Pharmaceuticals (Basel) Esparza-Rodríguez N, Solís-Flores NJ, Medellín-Zapata GG, Segoviano-Ramírez JC, Carcaño-Díaz K, Ortega-Martínez M, Jaramillo-Rangel G, García-Juárez J. PMID: 41304897 [PubMed]
	Elderly Men with De Novo Metastatic Castration-Sensitive Prostate Cancer: Therapy and Does Comorbidity Matter. Medicina (Kaunas) Ozberk U, Esen SA, Uguz A, Alg, Bal O, Ak, Uncu D. PMID: 41303903 [PubMed - indexed for MEDLINE]
	Comparative Effectiveness and Safety of Finasteride and Dutasteride in the Treatment of Benign Prostatic Hyperplasia: A Real-World Retrospective Study. Medicina (Kaunas) Ratajski J, Ciechan K, J, Kaminski TW, Uciechowski P, Z. PMID: 41303781 [PubMed - indexed for MEDLINE]
	Circulating Tumor DNA as a Biomarker for Precision Medicine in Prostate Cancer: A Systematic Review. Int J Mol Sci Chanhih N, Laraqui A, Hassine S, Ameur A, Hamedoun L, El Annaz H, Abi R, Tagajdid MR, Amine IL, Ennibi K, Benjouad A, Belayachi L. PMID: 41303533 [PubMed - indexed for MEDLINE]
	Surgical Treatment for Localized Prostate Cancer: A Narrative Review of Literature. J Clin Med Salamone V, Mazzola L, Conte FL, Conte F, Giustozzi B, Saladino M, Paganelli D, Carli G, Lipparini F, Vittori G, Oriti R, Salvi M, Lambertini L, Di Maida F, Mari A, Minervini A, Grosso AA. PMID: 41303179 [PubMed]
	Clinical Experience with URO17(Â®) in the Diagnosis and Surveillance of Bladder Cancer. J Clin Med Gholami SS, Movassaghi M, Homayoun S, Vasdev N. PMID: 41303144 [PubMed]
	A Feasibility Study of Co-Established Patient-Derived Subcutaneous Xenograft and Organotypic Slice Cultures in Hormone-Naive Primary Prostate Cancer Preclinical Modeling: A Single-Institution Experience. Life (Basel) Pecci V, Borsa M, Aiello A, De Martino S, Cis L, Pierconti F, Varacalli D, Bracco M, Ripoli C, Pinto F, Rotili D, Grassi C, Gaetano C, Pontecorvi A, Farsetti A, Nanni S. PMID: 41302142 [PubMed]
	Toxicological Impacts and Mechanistic Insights of Bisphenol a on Clear Cell Renal Cell Carcinoma Progression: A Network Toxicology, Machine Learning and Molecular Docking Study. Biomedicines Chen J, Ran B, Chen B, Bai J, Jian S, Huang Y, Yang J, Li J, Chen Z, Wei Q, Ai J, Liu L, Cao D. PMID: 41301871 [PubMed]
	Association Between Renal Cell Cancer and Chronic Kidney Disease: An Update on a Never-Healing Wound. Biomedicines Giannakodimos I, Kaltsas A, Koumenis A, Mitakidi E, Adamos K, Deligiannis D, Stavropoulos M, Kratiras Z, Chrisofos M. PMID: 41301732 [PubMed]
	PSMA Theranostics in Prostate Cancer and Beyond: Current and Future Perspectives. Cancers (Basel) Sandhu K, Chen D, Hennes D, Murphy DG, Lawrentschuk N, Perera M. PMID: 41301079 [PubMed]
	Rho Small GTPase Family in Androgen-Regulated Prostate Cancer Progression and Metastasis. Cancers (Basel) Hairston DWS, Mudryj M, Ghosh PM. PMID: 41301045 [PubMed]

Articles 1 - 20 / 297054

Page 1 of 14853



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy